Page 147 - Read Online

18 FDG PET/CT) to establish a role for 99m Tc-TF SPECT Manca G, Rubello D, Strauss HW, Mariani G. The role of 99mTc-
in therapy, as well as prognosis of head and neck cancers. tetrofosmin scintigraphy for staging patients with laryngeal cancer.
Cancer Biother Radiopharm 2005;20:27-35.
Financial support and sponsorship 15. Shen YY, Kao CH, Changlai SP, Chieng PU, Yen TC. Detection of
Nil. nasopharyngeal carcinoma with head and neck Tc-99m tetrofosmin
SPECT imaging. Clin Nucl Med 1998;23:305-8.
16. Pui MH, Du JQ, Yueh TC, Zeng SQ. Imaging of nasopharyngeal
Conflicts of interest carcinoma with Tc-99m MIBI. Clin Nucl Med 1998;23:29-32.
There are no conflicts of interest. 17. Kostakoglu L, Uysal U, Ozyar E, Hayran M, Uzal D, Demirkazïk
FB, Kars A, Atahan L, Bekdik CF. Monitoring response to therapy
REFERENCES with thallium-201 and technetium-99m-sestamibi SPECT in
nasopharyngeal carcinoma. J Nucl Med 1997;38:1009-14.
1. Czerny C, Formanek M. Malignant tumors of the pharynx. Radiologe 18. Guney E, Yigitbasi OG, Tutus A, Bozdemir K, Nardali M. Value of
2000;40:625-31. thallium-201 scintigraphy for primary tumour detection in patients
2. Vermeersch H, Loose D, Ham H, Otte A, Van de Wiele C. Nuclear with malignant neck masses. Eur J Nucl Med 1998;25:431-4.
medicine imaging for the assessment of primary and recurrent head 19. Wang SJ, Hsu CY, Lin WY, Kao CH, Jan JS, Yeh SH. Comparison
and neck carcinoma using routinely available tracers. Eur J Nucl Med of TI-201 and Tc-99m MIBI SPECT imaging in nasopharyngeal
Mol Imaging 2003;30:1689-700. carcinoma. Clin Nucl Med 1995;20:800-2.
3. Manolidis S, Donald PJ, Volk P, Pounds TR. The use of positron 20. Gregor RT, Valdes-Olmos R, Koops W, Balm AJ, Hilgers FJ,
emission tomography scanning in occult and recurrent head and neck Hoefnagel CA. Preliminary experience with thallous chloride
cancer. Acta Otolaryngol Suppl 1998;534:1-11. T1 201-labeled single-photon emission computed tomography
4. Nowak B, Di Martino E, Jänicke S, Cremerius U, Adam G, Zimny M, scanning in head and neck cancer. Arch Otolaryngol Head Neck Surg
Reinartz P, Büll U. Diagnostic evaluation of malignant head and neck 1996;122:509-14.
cancer by F-18-FDG PET compared to CT/MRI. Nuklearmedizin 21. Mukherji SK, Gapany M, Phillips D, Neelon B, O’Brien S,
1999;38:312-8. McCartney W, Buejenovich S, Parekh JS, Noordzij JP, Castillo M.
5. Pöpperl G, Lang S, Dagdelen O, Jäger L, Tiling R, Hahn K, Tatsch Thallium-201 single-photon emission CT versus CT for the detection
K. Correlation of FDG-PET and MRI/CT with histopathology in of recurrent squamous cell carcinoma of the head and neck. AJNR Am
primary diagnosis, lymph node staging and diagnosis of recurrency J Neuroradiol 1999;20:1215-20.
of head and neck cancer. Rofo 2002;174:714-20. (in German) 22. Shiau YC, Tsai SC, Ho YJ, Kao CH. Comparison of technetium-
6. Benchaou M, Lehmann W, Slosman DO, Becker M, Lemoine R, 99m methoxyisobutylisonitrile single photon emission computed
Rufenacht D, Donath A. The role of FDG-PET in the preoperative tomography and computed tomography to detect recurrent or residual
assessment of N-staging in head and neck cancer. Acta Otolaryngol nasopharyngeal carcinomas after radiotherapy. Anticancer Res 2001;
1996;116:332-5. 21:2213-7.
7. Stuckensen T, Kovacs AF, Adams S, Baum RP. Staging of the neck 23. Kao CH, Shiau YC, Shen YY, Yen RF. Detection of recurrent or
in patients with oral cavity squamous cell carcinomas: a prospective persistent nasopharyngeal carcinomas after radiotherapy with
comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac technetium-99m methoxyisobutylisonitrile single photon emission
Surg 2000;28:319-24. computed tomography and computed tomography: comparison with
8. Hannah A, Scott AM, Tochon-Danguy H, Chan JG, Akhurst T, 18-fluoro-2-deoxyglucose positron emission tomography. Cancer
Berlangieri S, Price D, Smith GJ, Schelleman T, McKay WJ, 2002;94:1981-6.
Sizeland A. Evaluation of 18 F-fluorodeoxyglucose positron emission 24. Sobic-Saranovic DP, Pendjer IP, Kozarevic N, Artiko VM, Mikic
tomography and computed tomography with histopathologic AA, Obradovic VB. Evaluation of undifferentiated carcinoma of
correlation in the initial staging of head and neck cancer. Ann Surg nasopharyngeal type with thallium-201 and technetium-99m MIBI
2002;236:208-17. SPECT. Otolaryngol Head Neck Surg 2007;137:405-11.
9. Kresnik E, Mikosch P, Gallowitsch HJ, Kogler D, Wiesser S, 25. Leitha T, Glaser C, Pruckmayer M, Rasse M, Millesi W, Lang S,
Heinisch M, Unterweger O, Raunik W, Kumnig G, Gomez I, Nasel C, Backfrieder W, Kainberger F. Technetium-99m-MIBI in
Grünbacher G, Lind P. Evaluation of head and neck cancer with primary and recurrent head and neck tumors: contribution of bone
18F-FDG PET: a comparison with conventional methods. Eur J Nucl SPECT image fusion. J Nucl Med 1998;39:1166-71.
Med 2001;28:816-21. 26. Nakamura K, Sammiya T, Hashimoto J, Ishibashi R, Matsumoto
10. Teknos TN, Rosenthal EL, Lee D, Taylor R, Marn CS. Positron K, Kubo A. Comparison of cationic myocardial perfusion agents:
emission tomography in the evaluation of stage III and IV head and characteristics of accumulation in cultured smooth muscle cells. Ann
neck cancer. Head Neck 2001;23:1056-60. Nucl Med 1996;10:375-81.
11. Li P, Zhuang H, Mozley PD, Denittis A, Yeh D, Machtay M, Smith 27. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial
R, Alavi A. Evaluation of recurrent squamous cell carcinoma of the and plasma membrane potentials on accumulation of hexakis
head and neck with FDG positron emission tomography. Clin Nucl (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse
Med 2001;26:131-5. fibroblasts. J Nucl Med 1990;31:1646-53.
12. Schillaci O, Spanu A, Madeddu G. [99mTc] sestamibi and [99mTc] 28. Crankshaw CL, Marmion M, Luker GD, Rao V, Dahlheimer J,
tetrofosmin in oncology: SPECT and fusion imaging in lung cancer, Burleigh BD, Webb E, Deutsch KF, Piwnica-Worms D. Novel
malignant lymphomas and brain tumors. Q J Nucl Med Mol Imaging technetium (III)-Q complexes for functional imaging of multidrug
2005;49:133-44. resistance (MDR1) P-glycoprotein. J Nucl Med 1998;39:77-86.
13. Kostakoglu L, Uysal U, Ozyar E, Demirkazik FB, Hayran M, Atahan 29. Márián T, Szabó G, Goda K, Nagy H, Szincsák N, Juhász I, Galuska
L, Bekdik CF. A comparative study of technetium-99m sestamibi L, Balkay L, Mikecz P, Trón L, Krasznai Z. In vivo and in vitro
and technetium-99m tetrofosmin single-photon tomography in multitracer analyses of P-glycoprotein expression-related multidrug
the detection of nasopharyngeal carcinoma. Eur J Nucl Med resistance. Eur J Nucl Med Mol Imaging 2003;30:1147-54.
1997;24:621-8. 30. Utsunomiya K, Ballinger JR, Piquette-Miller M, Rauth AM, Tang W,
14. Fattori B, Grosso M, Nacci A, Bianchi F, Cosottini M, Ursino F, Su ZF, Ichise M. Comparison of the accumulation and efflux kinetics

Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ April 15, 2016 ¦ 137